Britt Borregaard, Jan Sørensen, Ola Ekholm, Jacob E Møller, Lars P Riber, Lars Thrysoee, Charlotte B Thorup, Marianne Vamosi, Anne V Christensen, Trine B Rasmussen, Selina K Berg
{"title":"社会人口学,临床和患者报告的结果和心脏瓣膜手术后再入院。","authors":"Britt Borregaard, Jan Sørensen, Ola Ekholm, Jacob E Møller, Lars P Riber, Lars Thrysoee, Charlotte B Thorup, Marianne Vamosi, Anne V Christensen, Trine B Rasmussen, Selina K Berg","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Readmissions after heart valve surgery represent a significant burden for both the patient and the healthcare system. The study aim was to identify independent predictors of readmission within 180 days after surgery in a population of patients undergoing heart valve surgery.</p><p><strong>Methods: </strong>Demographic and clinical information was obtained from national registers. Patient-reported outcomes (PROs) including Short Form 12 (SF-12) and EuroQol 5D (EQ-5D) were measured at discharge as part of a national, cross-sectional study (DenHeart). Predictors of first readmission were investigated.</p><p><strong>Results: </strong>Among a total of 1,084 patients (65% men; mean age 68 years; 354 responded to questionnaires), 534 (49%) were readmitted. Responding patients who were readmitted were younger and a greater proportion had undergone mitral valve surgery. A significantly higher proportion of non-responders was readmitted. No significant differences were found in PROs between patients readmitted and those not readmitted, and receiver operating characteristic (ROC) curves showed no predictive effect of SF-12 and EQ-5D. Survival analysis using Cox proportional hazard models showed that prior percutaneous coronary intervention (PCI) (HR 1.50, CI 1.10; 2.05, p = 0.010) and a history of heart failure (HR 1.37, CI 1.10; 1.72, p = 0.006) were predictive of readmission.</p><p><strong>Conclusions: </strong>Readmission rates after heart valve surgery are high and often seen in patients who have undergone PCI and heart failure before surgery. Predictors for these high readmissions rates are difficult to establish based on medical history and type of surgery. PROs at discharge contribute information regarding a patient's perception of their often poor quality of life, but do not predict readmission.</p>","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"27 1","pages":"78-86"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sociodemographic, Clinical and Patient-Reported Outcomes and Readmission After Heart Valve Surgery.\",\"authors\":\"Britt Borregaard, Jan Sørensen, Ola Ekholm, Jacob E Møller, Lars P Riber, Lars Thrysoee, Charlotte B Thorup, Marianne Vamosi, Anne V Christensen, Trine B Rasmussen, Selina K Berg\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Readmissions after heart valve surgery represent a significant burden for both the patient and the healthcare system. The study aim was to identify independent predictors of readmission within 180 days after surgery in a population of patients undergoing heart valve surgery.</p><p><strong>Methods: </strong>Demographic and clinical information was obtained from national registers. Patient-reported outcomes (PROs) including Short Form 12 (SF-12) and EuroQol 5D (EQ-5D) were measured at discharge as part of a national, cross-sectional study (DenHeart). Predictors of first readmission were investigated.</p><p><strong>Results: </strong>Among a total of 1,084 patients (65% men; mean age 68 years; 354 responded to questionnaires), 534 (49%) were readmitted. Responding patients who were readmitted were younger and a greater proportion had undergone mitral valve surgery. A significantly higher proportion of non-responders was readmitted. No significant differences were found in PROs between patients readmitted and those not readmitted, and receiver operating characteristic (ROC) curves showed no predictive effect of SF-12 and EQ-5D. Survival analysis using Cox proportional hazard models showed that prior percutaneous coronary intervention (PCI) (HR 1.50, CI 1.10; 2.05, p = 0.010) and a history of heart failure (HR 1.37, CI 1.10; 1.72, p = 0.006) were predictive of readmission.</p><p><strong>Conclusions: </strong>Readmission rates after heart valve surgery are high and often seen in patients who have undergone PCI and heart failure before surgery. Predictors for these high readmissions rates are difficult to establish based on medical history and type of surgery. PROs at discharge contribute information regarding a patient's perception of their often poor quality of life, but do not predict readmission.</p>\",\"PeriodicalId\":50184,\"journal\":{\"name\":\"Journal of Heart Valve Disease\",\"volume\":\"27 1\",\"pages\":\"78-86\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Heart Valve Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Heart Valve Disease","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
背景:心脏瓣膜手术后再入院对患者和医疗保健系统都是一个重大负担。该研究的目的是确定心脏瓣膜手术患者术后180天内再入院的独立预测因素。方法:从国家登记处获得人口统计和临床信息。患者报告的预后(PROs)包括短表12 (SF-12)和EuroQol 5D (EQ-5D)在出院时作为国家横断面研究(DenHeart)的一部分进行测量。研究了首次再入院的预测因素。结果:共1084例患者(65%男性;平均年龄68岁;354人回复问卷),534人(49%)再次入院。再次入院的应答患者更年轻,并且接受二尖瓣手术的比例更高。无应答者再次入院的比例明显更高。再入院患者与未再入院患者的pro无显著差异,受试者工作特征(ROC)曲线显示SF-12和EQ-5D无预测作用。Cox比例风险模型的生存分析显示,既往经皮冠状动脉介入治疗(PCI) (HR 1.50, CI 1.10;2.05, p = 0.010)和心力衰竭史(HR 1.37, CI 1.10;1.72, p = 0.006)预测再入院。结论:心脏瓣膜手术后再入院率高,且常见于术前接受过PCI和心力衰竭的患者。这些高再入院率的预测因素很难根据病史和手术类型来确定。出院时的专家提供了关于患者对他们通常较差的生活质量的感知的信息,但不能预测再入院。
Sociodemographic, Clinical and Patient-Reported Outcomes and Readmission After Heart Valve Surgery.
Background: Readmissions after heart valve surgery represent a significant burden for both the patient and the healthcare system. The study aim was to identify independent predictors of readmission within 180 days after surgery in a population of patients undergoing heart valve surgery.
Methods: Demographic and clinical information was obtained from national registers. Patient-reported outcomes (PROs) including Short Form 12 (SF-12) and EuroQol 5D (EQ-5D) were measured at discharge as part of a national, cross-sectional study (DenHeart). Predictors of first readmission were investigated.
Results: Among a total of 1,084 patients (65% men; mean age 68 years; 354 responded to questionnaires), 534 (49%) were readmitted. Responding patients who were readmitted were younger and a greater proportion had undergone mitral valve surgery. A significantly higher proportion of non-responders was readmitted. No significant differences were found in PROs between patients readmitted and those not readmitted, and receiver operating characteristic (ROC) curves showed no predictive effect of SF-12 and EQ-5D. Survival analysis using Cox proportional hazard models showed that prior percutaneous coronary intervention (PCI) (HR 1.50, CI 1.10; 2.05, p = 0.010) and a history of heart failure (HR 1.37, CI 1.10; 1.72, p = 0.006) were predictive of readmission.
Conclusions: Readmission rates after heart valve surgery are high and often seen in patients who have undergone PCI and heart failure before surgery. Predictors for these high readmissions rates are difficult to establish based on medical history and type of surgery. PROs at discharge contribute information regarding a patient's perception of their often poor quality of life, but do not predict readmission.
期刊介绍:
The Journal of Heart Valve Disease (ISSN 0966-8519) is the official journal of The Society for Heart Valve Disease. It is indexed/abstracted by Index Medicus, Medline, Medlar, PubMed, Science Citation Index, Scisearch, Research Alert, Biomedical Products, Current Contents/Clinical Medicine. It is issued bi-monthly in one indexed volume by ICR Publishers Ltd., Crispin House, 12A South Approach, Moor Park, Northwood HA6 2ET, United Kingdom. This paper meets the requirements of ANSI standard Z39.48-1992 (Permanence of Paper).